Gary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor
Advertisement
Articles by Gary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
2
U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels
3
Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement
4
Novartis to Layoff 322 NJ Employees: Report
5